Literature DB >> 9306434

The risk of diplopia following orbital floor and medial wall decompression in subtypes of ophthalmic Graves' disease.

W R Nunery1, C W Nunery, R T Martin, T V Truong, D R Osborn.   

Abstract

We preoperatively divided 58 ophthalmic Graves' disease patients into types I and II categories before two-wall orbital decompression. Type I classification was given to patients who had no diplopia and essentially normal versions. Type II classification was assigned to patients with restrictive motility loss and diplopia within 20 degrees of the primary position. Ocular motility was assessed before and after two-wall orbital decompression. Only one of 25 type I patients (4%) experienced diplopia after orbital decompression, while seven of 14 (50%) (p = 0.001) type II patients without preoperative primary-position diplopia had primary diplopia postoperatively. Of 12 type II patients who had preoperative primary-position diplopia, esotropia increased by an average of 12.4 diopters postoperatively. Vertical deviation increased an average of 13.4 diopters for 10 patients who underwent unilateral two-wall decompression. The likelihood of new or worsening diplopia in all type II patients following decompression was 22 of 36 (61%). We conclude that adverse motility change following two-wall orbital decompression is rare in type I disease patients, but it occurs 61% of the time in type II disease patients. Predicting preoperatively which patients are likely to develop adverse motility change and diplopia may help clarify indications and risks of orbital decompression surgery in patients with ophthalmic Graves' disease.

Entities:  

Mesh:

Year:  1997        PMID: 9306434     DOI: 10.1097/00002341-199709000-00001

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  21 in total

Review 1.  [Endocrine orbit disorders. Pathogenesis, clinical presentation and examination, stage-dependent therapy].

Authors:  A Eckstein; J Esser
Journal:  Ophthalmologe       Date:  2003-10       Impact factor: 1.059

2.  [Two-wall decompression without resection of the medial wall. Effect on squint angle].

Authors:  E Bertelmann; K Rüther
Journal:  Ophthalmologe       Date:  2011-11       Impact factor: 1.059

3.  The role of thyroid eye disease and other factors in the overcorrection of hypotropia following unilateral adjustable suture recession of the inferior rectus (an American Ophthalmological Society thesis).

Authors:  Natalie C Kerr
Journal:  Trans Am Ophthalmol Soc       Date:  2011-12

4.  Imaging biomarkers in thyroid eye disease and their clinical associations.

Authors:  Shikha Chaganti; Katrina Nelson; Kevin Mundy; Robert Harrigan; Robert Galloway; Louise A Mawn; Bennett Landman
Journal:  J Med Imaging (Bellingham)       Date:  2018-10-16

5.  CT features of exophthalmos in Chinese subjects with thyroid-associated ophthalmopathy.

Authors:  Zhi-Jia Fang; Jenny Y Zhang; Wei-Min He
Journal:  Int J Ophthalmol       Date:  2013-04-18       Impact factor: 1.779

Review 6.  Iatrogenic diplopia [corrected].

Authors:  Julio González-Martín-Moro; Julio José González-López; Marco Sales-Sanz; Andrea Sales-Sanz; Javier González-Martín-Moro; Fernando Gómez-Sanz; Mar González-Manrique; Belén Pilo-de-la-Fuente; Roberto García-Leal
Journal:  Int Ophthalmol       Date:  2014-03-07       Impact factor: 2.031

7.  Comparison of lateral orbital decompression with and without rim repositioning in thyroid eye disease.

Authors:  Oded Sagiv; Khami Satchi; Michael Kinori; Ido D Fabian; Nachum Rosen; Guy J Ben Simon; Alan McNab
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-12-19       Impact factor: 3.117

8.  Electronic Medical Record Context Signatures Improve Diagnostic Classification Using Medical Image Computing.

Authors:  Shikha Chaganti; Louise A Mawn; Hakmook Kang; Josephine Egan; Susan M Resnick; Lori L Beason-Held; Bennett A Landman; Thomas A Lasko
Journal:  IEEE J Biomed Health Inform       Date:  2018-12-28       Impact factor: 5.772

Review 9.  Immune mechanisms in thyroid eye disease.

Authors:  Geniece M Lehmann; Steven E Feldon; Terry J Smith; Richard P Phipps
Journal:  Thyroid       Date:  2008-09       Impact factor: 6.568

10.  Update on thyroid eye disease and management.

Authors:  Erick D Bothun; Ryan A Scheurer; Andrew R Harrison; Michael S Lee
Journal:  Clin Ophthalmol       Date:  2009-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.